We look forward to re-connecting with clients/colleagues at the first on-site SOT in two years, held this year in San Diego between 27-31 March.
MicroMatrices will be presenting at the InSphero exhibitor hosted session planned for Tuesday 29 between 12-1, Room 23A . This will focus on the progress to date of the pharma-sponsored cross species consortium designed to recapitulate in vivo tox findings for DILI-inducing compounds in InSphero liver spheroid models from 4 species: human rat, dog and monkey. MicroMatrices are generating histopathology (H&E) images of the models for the consortium using our SpheroMatrices microTMA technology.
Also, we have a poster on Monday 28 March entitled “Adverse Outcome Pathway Screening for Cross-Species Risk Assessment in 3D Liver Microtissues” (Abstract Number/Poster Board number:3150/P277) 3150/P277) .
Histology and Microphysiological systems (MPS)
In vitro 3D models are increasingly integral to drug discovery and drug development programs with many commercial safety…
Meet us in San Diego at SOT 2022
We look forward to re-connecting with clients/colleagues at the first on-site SOT in two years, held this year…
Transcriptomics with SpheroMatrices microTMA
The addition of a spatially defined overlay of transcriptomics to cytotoxicity/histological findings, or biomarker expression/localization image data, adds…
on an interactive, step by step basis. Collaborations can begin with pilot projects which can then be scaled up to larger research programs, according to your requirements.